Interestingly, Lee et al. found that the expression of DKK-1 is increased in the sera of newly diagnosed osteosarcoma patients, suggesting the potential need to inhibit the Wnt/β-catenin pathway at the onset of osteosarcoma carcinogenesis [141]. This evidence concerns the gene DKK1 and osteosarcoma.